Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2003 Sep 1;374(Pt 2):453–461. doi: 10.1042/BJ20030705

Distinct regulation of cytosolic phospholipase A2 phosphorylation, translocation, proteolysis and activation by tumour necrosis factor-receptor subtypes.

Orla J Jupp 1, Peter Vandenabeele 1, David J MacEwan 1
PMCID: PMC1223607  PMID: 12786601

Abstract

The hormonally regulated Ca(2+)-dependent enzyme, cytosolic phospholipase A(2) (cPLA(2)) is activated by a range of inflammatory stimuli. Tumour necrosis factor-alpha (TNF) is one of the first known stimuli for cPLA(2) but it is not known whether both TNF receptor subtypes are involved in activating the lipase. In the present study, we show for the first time that both type I 55 kDa TNFR (TNFR1) and type II 75 kDa TNFR (TNFR2) stimulate cPLA(2) enzyme, but with distinct signalling mechanisms. TNFR1 activates mitogen-activated protein kinase (MAPK) and p38MAPK. TNFR1 then phosphorylates and activates cPLA(2) in a MAPK-dependent fashion. Furthermore, TNFR1 causes the translocation and caspase-dependent proteolysis of cPLA(2) as part of its activation profile. TNFR2, on the other hand, does not cause the phosphorylation of cPLA(2) as it does not activate MAPK or p38MAPK, but instead activates cPLA(2) by causing its translocation to plasma membrane and perinuclear subcellular regions. TNFR2 activation causes a delayed, slight increase in [Ca(2+)](i) of <50 nM that may contribute towards the translocation and activation of cPLA(2). Therefore both TNF receptor subtypes play a role in cPLA(2) activation, but by means of separate signal-transduction pathways.

Full Text

The Full Text of this article is available as a PDF (270.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam-Klages S., Schwandner R., Lüschen S., Ussat S., Kreder D., Krönke M. Caspase-mediated inhibition of human cytosolic phospholipase A2 during apoptosis. J Immunol. 1998 Nov 15;161(10):5687–5694. [PubMed] [Google Scholar]
  2. Atsumi G., Tajima M., Hadano A., Nakatani Y., Murakami M., Kudo I. Fas-induced arachidonic acid release is mediated by Ca2+-independent phospholipase A2 but not cytosolic phospholipase A2, which undergoes proteolytic inactivation. J Biol Chem. 1998 May 29;273(22):13870–13877. doi: 10.1074/jbc.273.22.13870. [DOI] [PubMed] [Google Scholar]
  3. Baxter G. T., Kuo R. C., Jupp O. J., Vandenabeele P., MacEwan D. J. Tumor necrosis factor-alpha mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression. J Biol Chem. 1999 Apr 2;274(14):9539–9547. doi: 10.1074/jbc.274.14.9539. [DOI] [PubMed] [Google Scholar]
  4. Börsch-Haubold A. G., Bartoli F., Asselin J., Dudler T., Kramer R. M., Apitz-Castro R., Watson S. P., Gelb M. H. Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells. J Biol Chem. 1998 Feb 20;273(8):4449–4458. doi: 10.1074/jbc.273.8.4449. [DOI] [PubMed] [Google Scholar]
  5. Börsch-Haubold A. G., Kramer R. M., Watson S. P. Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets. Eur J Biochem. 1997 May 1;245(3):751–759. doi: 10.1111/j.1432-1033.1997.t01-1-00751.x. [DOI] [PubMed] [Google Scholar]
  6. Chang D. J., Ringold G. M., Heller R. A. Cell killing and induction of manganous superoxide dismutase by tumor necrosis factor-alpha is mediated by lipoxygenase metabolites of arachidonic acid. Biochem Biophys Res Commun. 1992 Oct 30;188(2):538–546. doi: 10.1016/0006-291x(92)91089-9. [DOI] [PubMed] [Google Scholar]
  7. Clark J. D., Lin L. L., Kriz R. W., Ramesha C. S., Sultzman L. A., Lin A. Y., Milona N., Knopf J. L. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell. 1991 Jun 14;65(6):1043–1051. doi: 10.1016/0092-8674(91)90556-e. [DOI] [PubMed] [Google Scholar]
  8. Clark J. D., Milona N., Knopf J. L. Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7708–7712. doi: 10.1073/pnas.87.19.7708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DOLE V. P., MEINERTZ H. Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem. 1960 Sep;235:2595–2599. [PubMed] [Google Scholar]
  10. De Valck D., Vercammen D., Fiers W., Beyaert R. Differential activation of phospholipases during necrosis or apoptosis: a comparative study using tumor necrosis factor and anti-Fas antibodies. J Cell Biochem. 1998 Dec 1;71(3):392–399. [PubMed] [Google Scholar]
  11. Decoster E., Vanhaesebroeck B., Vandenabeele P., Grooten J., Fiers W. Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor. J Biol Chem. 1995 Aug 4;270(31):18473–18478. doi: 10.1074/jbc.270.31.18473. [DOI] [PubMed] [Google Scholar]
  12. Dessen A. Structure and mechanism of human cytosolic phospholipase A(2). Biochim Biophys Acta. 2000 Oct 31;1488(1-2):40–47. doi: 10.1016/s1388-1981(00)00108-6. [DOI] [PubMed] [Google Scholar]
  13. El Mahdani N. E., Ameyar M., Cai Z., Colard O., Masliah J., Chouaib S. Resistance to TNF-induced cytotoxicity correlates with an abnormal cleavage of cytosolic phospholipase A2. J Immunol. 2000 Dec 15;165(12):6756–6761. doi: 10.4049/jimmunol.165.12.6756. [DOI] [PubMed] [Google Scholar]
  14. Gilbert J. J., Stewart A., Courtney C. A., Fleming M. C., Reid P., Jackson C. G., Wise A., Wakelam M. J., Harnett M. M. Antigen receptors on immature, but not mature, B and T cells are coupled to cytosolic phospholipase A2 activation: expression and activation of cytosolic phospholipase A2 correlate with lymphocyte maturation. J Immunol. 1996 Mar 15;156(6):2054–2061. [PubMed] [Google Scholar]
  15. Glover S., de Carvalho M. S., Bayburt T., Jonas M., Chi E., Leslie C. C., Gelb M. H. Translocation of the 85-kDa phospholipase A2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen. J Biol Chem. 1995 Jun 23;270(25):15359–15367. doi: 10.1074/jbc.270.25.15359. [DOI] [PubMed] [Google Scholar]
  16. Grell M., Douni E., Wajant H., Löhden M., Clauss M., Maxeiner B., Georgopoulos S., Lesslauer W., Kollias G., Pfizenmaier K. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell. 1995 Dec 1;83(5):793–802. doi: 10.1016/0092-8674(95)90192-2. [DOI] [PubMed] [Google Scholar]
  17. Hayakawa M., Ishida N., Takeuchi K., Shibamoto S., Hori T., Oku N., Ito F., Tsujimoto M. Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J Biol Chem. 1993 May 25;268(15):11290–11295. [PubMed] [Google Scholar]
  18. Hazan-Halevy I., Seger R., Levy R. The requirement of both extracellular regulated kinase and p38 mitogen-activated protein kinase for stimulation of cytosolic phospholipase A(2) activity by either FcgammaRIIA or FcgammaRIIIB in human neutrophils. A possible role for Pyk2 but not for the Grb2-Sos-Shc complex. J Biol Chem. 2000 Apr 28;275(17):12416–12423. doi: 10.1074/jbc.275.17.12416. [DOI] [PubMed] [Google Scholar]
  19. Hirabayashi T., Kume K., Hirose K., Yokomizo T., Iino M., Itoh H., Shimizu T. Critical duration of intracellular Ca2+ response required for continuous translocation and activation of cytosolic phospholipase A2. J Biol Chem. 1999 Feb 19;274(8):5163–5169. doi: 10.1074/jbc.274.8.5163. [DOI] [PubMed] [Google Scholar]
  20. Hirabayashi T., Shimizu T. Localization and regulation of cytosolic phospholipase A(2). Biochim Biophys Acta. 2000 Oct 31;1488(1-2):124–138. doi: 10.1016/s1388-1981(00)00115-3. [DOI] [PubMed] [Google Scholar]
  21. Hoeck W. G., Ramesha C. S., Chang D. J., Fan N., Heller R. A. Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4475–4479. doi: 10.1073/pnas.90.10.4475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jayadev S., Hayter H. L., Andrieu N., Gamard C. J., Liu B., Balu R., Hayakawa M., Ito F., Hannun Y. A. Phospholipase A2 is necessary for tumor necrosis factor alpha-induced ceramide generation in L929 cells. J Biol Chem. 1997 Jul 4;272(27):17196–17203. doi: 10.1074/jbc.272.27.17196. [DOI] [PubMed] [Google Scholar]
  23. Jupp O. J., McFarlane S. M., Anderson H. M., Littlejohn A. F., Mohamed A. A., MacKay R. H., Vandenabeele P., MacEwan D. J. Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways. Biochem J. 2001 Nov 1;359(Pt 3):525–535. doi: 10.1042/0264-6021:3590525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jättelä M., Wissing D., Kokholm K., Kallunki T., Egeblad M. Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J. 1998 Nov 2;17(21):6124–6134. doi: 10.1093/emboj/17.21.6124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kramer R. M., Roberts E. F., Manetta J. V., Hyslop P. A., Jakubowski J. A. Thrombin-induced phosphorylation and activation of Ca(2+)-sensitive cytosolic phospholipase A2 in human platelets. J Biol Chem. 1993 Dec 15;268(35):26796–26804. [PubMed] [Google Scholar]
  26. Kramer R. M., Roberts E. F., Manetta J., Putnam J. E. The Ca2(+)-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells. J Biol Chem. 1991 Mar 15;266(8):5268–5272. [PubMed] [Google Scholar]
  27. Kramer R. M., Roberts E. F., Strifler B. A., Johnstone E. M. Thrombin induces activation of p38 MAP kinase in human platelets. J Biol Chem. 1995 Nov 17;270(46):27395–27398. doi: 10.1074/jbc.270.46.27395. [DOI] [PubMed] [Google Scholar]
  28. Kramer R. M., Roberts E. F., Um S. L., Börsch-Haubold A. G., Watson S. P., Fisher M. J., Jakubowski J. A. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J Biol Chem. 1996 Nov 1;271(44):27723–27729. doi: 10.1074/jbc.271.44.27723. [DOI] [PubMed] [Google Scholar]
  29. Lin L. L., Wartmann M., Lin A. Y., Knopf J. L., Seth A., Davis R. J. cPLA2 is phosphorylated and activated by MAP kinase. Cell. 1993 Jan 29;72(2):269–278. doi: 10.1016/0092-8674(93)90666-e. [DOI] [PubMed] [Google Scholar]
  30. Lüschen S., Ussat S., Krönke M., Adam-Klages S. Cleavage of human cytosolic phospholipase A2 by caspase-1 (ICE) and caspase-8 (FLICE). Biochem Biophys Res Commun. 1998 Dec 9;253(1):92–98. doi: 10.1006/bbrc.1998.9754. [DOI] [PubMed] [Google Scholar]
  31. MacEwan D. J. Elevated cPLA2 levels as a mechanism by which the p70 TNF and p75 NGF receptors enhance apoptosis. FEBS Lett. 1996 Jan 22;379(1):77–81. doi: 10.1016/0014-5793(95)01495-0. [DOI] [PubMed] [Google Scholar]
  32. MacEwan David J. TNF ligands and receptors--a matter of life and death. Br J Pharmacol. 2002 Feb;135(4):855–875. doi: 10.1038/sj.bjp.0704549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. McFarlane S. M., Anderson H. M., Tucker S. J., Jupp O. J., MacEwan D. J. Unmodified calcium concentrations in tumour necrosis factor receptor subtype-mediated apoptotic cell death. Mol Cell Biochem. 2000 Aug;211(1-2):19–26. doi: 10.1023/a:1007189911897. [DOI] [PubMed] [Google Scholar]
  34. McFarlane S. M., Jupp O. J., Cobban H. J., Hunter I., Anderson H. M., Vandenabeele P., Nixon G. F., MacEwan D. J. Stimulation of stress-activated but not mitogen-activated protein kinases by tumour necrosis factor receptor subtypes in airway smooth muscle. Biochem Pharmacol. 2001 Mar 15;61(6):749–759. doi: 10.1016/s0006-2952(01)00530-5. [DOI] [PubMed] [Google Scholar]
  35. Mohamed Ahmed A. A., Jupp Orla J., Anderson Helen M., Littlejohn Alison F., Vandenabeele Peter, MacEwan David J. Tumour necrosis factor-induced activation of c-Jun N-terminal kinase is sensitive to caspase-dependent modulation while activation of mitogen-activated protein kinase (MAPK) or p38 MAPK is not. Biochem J. 2002 Aug 15;366(Pt 1):145–155. doi: 10.1042/BJ20020527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Nemenoff R. A., Winitz S., Qian N. X., Van Putten V., Johnson G. L., Heasley L. E. Phosphorylation and activation of a high molecular weight form of phospholipase A2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J Biol Chem. 1993 Jan 25;268(3):1960–1964. [PubMed] [Google Scholar]
  37. O'Brien J. B., Piddington D. L., Voelkel-Johnson C., Richards D. J., Hadley L. A., Laster S. M. Sustained phosphorylation of cytosolic phospholipase A2 accompanies cycloheximide- and adenovirus-induced susceptibility to TNF. J Immunol. 1998 Aug 1;161(3):1525–1532. [PubMed] [Google Scholar]
  38. Peters-Golden M., Song K., Marshall T., Brock T. Translocation of cytosolic phospholipase A2 to the nuclear envelope elicits topographically localized phospholipid hydrolysis. Biochem J. 1996 Sep 15;318(Pt 3):797–803. doi: 10.1042/bj3180797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Reid T., Louie P., Heller R. A. Mechanisms of tumor necrosis factor cytotoxicity and the cytotoxic signals transduced by the p75-tumor necrosis factor receptor. Circ Shock. 1994 Oct;44(2):84–90. [PubMed] [Google Scholar]
  40. Sapirstein A., Bonventre J. V. Specific physiological roles of cytosolic phospholipase A(2) as defined by gene knockouts. Biochim Biophys Acta. 2000 Oct 31;1488(1-2):139–148. doi: 10.1016/s1388-1981(00)00116-5. [DOI] [PubMed] [Google Scholar]
  41. Schievella A. R., Chen J. H., Graham J. R., Lin L. L. MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase. J Biol Chem. 1997 May 2;272(18):12069–12075. doi: 10.1074/jbc.272.18.12069. [DOI] [PubMed] [Google Scholar]
  42. Schievella A. R., Regier M. K., Smith W. L., Lin L. L. Calcium-mediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum. J Biol Chem. 1995 Dec 22;270(51):30749–30754. doi: 10.1074/jbc.270.51.30749. [DOI] [PubMed] [Google Scholar]
  43. Sharp J. D., White D. L., Chiou X. G., Goodson T., Gamboa G. C., McClure D., Burgett S., Hoskins J., Skatrud P. L., Sportsman J. R. Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2. J Biol Chem. 1991 Aug 15;266(23):14850–14853. [PubMed] [Google Scholar]
  44. Sierra-Honigmann M. R., Bradley J. R., Pober J. S. "Cytosolic" phospholipase A2 is in the nucleus of subconfluent endothelial cells but confined to the cytoplasm of confluent endothelial cells and redistributes to the nuclear envelope and cell junctions upon histamine stimulation. Lab Invest. 1996 Mar;74(3):684–695. [PubMed] [Google Scholar]
  45. Suffys P., Beyaert R., De Valck D., Vanhaesebroeck B., Van Roy F., Fiers W. Tumour-necrosis-factor-mediated cytotoxicity is correlated with phospholipase-A2 activity, but not with arachidonic acid release per se. Eur J Biochem. 1991 Jan 30;195(2):465–475. doi: 10.1111/j.1432-1033.1991.tb15727.x. [DOI] [PubMed] [Google Scholar]
  46. Syrbu S. I., Waterman W. H., Molski T. F., Nagarkatti D., Hajjar J. J., Sha'afi R. I. Phosphorylation of cytosolic phospholipase A2 and the release of arachidonic acid in human neutrophils. J Immunol. 1999 Feb 15;162(4):2334–2340. [PubMed] [Google Scholar]
  47. Vandenabeele P., Declercq W., Beyaert R., Fiers W. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol. 1995 Oct;5(10):392–399. doi: 10.1016/s0962-8924(00)89088-1. [DOI] [PubMed] [Google Scholar]
  48. Voelkel-Johnson C., Thorne T. E., Laster S. M. Susceptibility to TNF in the presence of inhibitors of transcription or translation is dependent on the activity of cytosolic phospholipase A2 in human melanoma tumor cells. J Immunol. 1996 Jan 1;156(1):201–207. [PubMed] [Google Scholar]
  49. Wajant H., Grell M., Scheurich P. TNF receptor associated factors in cytokine signaling. Cytokine Growth Factor Rev. 1999 Mar;10(1):15–26. doi: 10.1016/s1359-6101(98)00023-9. [DOI] [PubMed] [Google Scholar]
  50. Waterman W. H., Molski T. F., Huang C. K., Adams J. L., Sha'afi R. I. Tumour necrosis factor-alpha-induced phosphorylation and activation of cytosolic phospholipase A2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils. Biochem J. 1996 Oct 1;319(Pt 1):17–20. doi: 10.1042/bj3190017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Wissing D., Mouritzen H., Egeblad M., Poirier G. G., Jättelä M. Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis. Proc Natl Acad Sci U S A. 1997 May 13;94(10):5073–5077. doi: 10.1073/pnas.94.10.5073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Woo C. H., Eom Y. W., Yoo M. H., You H. J., Han H. J., Song W. K., Yoo Y. J., Chun J. S., Kim J. H. Tumor necrosis factor-alpha generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade. J Biol Chem. 2000 Oct 13;275(41):32357–32362. doi: 10.1074/jbc.M005638200. [DOI] [PubMed] [Google Scholar]
  53. Wu Y. L., Jiang X. R., Lillington D. M., Allen P. D., Newland A. C., Kelsey S. M. 1,25-Dihydroxyvitamin D3 protects human leukemic cells from tumor necrosis factor-induced apoptosis via inactivation of cytosolic phospholipase A2. Cancer Res. 1998 Feb 15;58(4):633–640. [PubMed] [Google Scholar]
  54. Wu Y. L., Jiang X. R., Newland A. C., Kelsey S. M. Failure to activate cytosolic phospholipase A2 causes TNF resistance in human leukemic cells. J Immunol. 1998 Jun 15;160(12):5929–5935. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES